跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,689 条关于
“high-risk lymphoma”
全部
64,689
临床试验
43,569
药物
502
机构
252
资讯
20,366
去年
Loncastuximab Tesirine Shows High Efficacy in Treating High-Risk Lymphoma Types
2个月前
UC Davis Comprehensive Cancer Center Showcases Smart Nanotechnology, Precision Imaging, and High-Risk Lymphoma Trial in Summer 2026 Synthesis Magazine
去年
Loncastuximab Tesirine Shows Promise in Relapsed/Refractory Follicular and Marginal Zone Lymphomas
10个月前
Estrella Immunopharma's EB103 Achieves 100% Complete Response Rate in High-Risk B-Cell Lymphoma Patients
9个月前
Miltenyi's Dual-Target CAR-T Therapy Shows Superior Efficacy in Pivotal Trial for Relapsed Large B-Cell Lymphoma
去年
CIT Therapeutics Secures $2.5M Partnership with IFLI to Advance Novel SUMOylation-Targeted Cancer Therapy
去年
FDA Issues Second Complete Response Letter for Odronextamab in Relapsed/Refractory Follicular Lymphoma
3个月前
Tafasitamab-Lenalidomide Combination Reduces Disease Progression Risk by 25% in High-Risk Aggressive B-Cell Lymphomas
2个月前
Multi-Omics Study Reveals Proteogenomic Signature of High-Risk Diffuse Large B-Cell Lymphoma
去年
Merck Highlights Hematology Pipeline at ASH 2024 with Zilovertamab Vedotin and Nemtabrutinib Data
第 1 页,共 2037 页
上一页
下一页